SHR-A2102 targets Nectin-4 on the cell surface, is internalized, and releases a topoisomerase I inhibitor that causes DNA damage and apoptosis. Topoisomerase I is the intracellular enzyme inhibited after delivery, not the antigen that determines cell targeting.